Session 3C: The new rules of biotechnology: Competing in the next generation of innovation
Tracks
Track 3
| Wednesday, October 21, 2026 |
| 3:05 PM - 3:50 PM |
| Discovery & Advanced Therapeutics Breakout Room |
Details
Biotechnology is entering a new era. Artificial intelligence, platform technologies and digital biology are transforming not only how medicines are discovered, but how biotechnology companies are built, how partnerships are formed and where competitive advantage is created. As traditional models give way to increasingly integrated, technology-enabled approaches, the next generation of biotechnology companies will look fundamentally different. Bringing together leaders in AI-enabled discovery, computational biology, platform innovation and digital R&D, this leadership discussion explores the forces reshaping biotechnology and the opportunities these changes present for companies, researchers and innovation ecosystems around the world.
Speaker
Dr. Jane Leong
Director and Chief Operating Officer
Australian Centre for AI in Medical Innovation
Chair
Dr. Craig Rayner
CEO and Founder
Oktopi
Panellist